JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.58, ss.537-542, 2006 (SCI-Expanded)
Objectives: This study was designed to demonstrate the prevalence of the newly discovered carbapenem-hydrolysing class D enzymes, OXA-51-type and OXA-58, among clinical isolates of Acinetobacter spp.